Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
8.24
-0.04 (-0.54%)
At close: Jun 27, 2025, 4:00 PM
8.25
+0.02 (0.18%)
After-hours: Jun 27, 2025, 4:34 PM EDT
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 32 employees as of December 31, 2024. The number of employees increased by 3 or 10.34% compared to the previous year.
Employees
32
Change (1Y)
3
Growth (1Y)
10.34%
Revenue / Employee
$966,000
Profits / Employee
-$451,188
Market Cap
227.44M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
FENC News
- 24 days ago - Fennec Announces Results of Annual Meeting - GlobeNewsWire
- 6 weeks ago - Fennec Pharmaceuticals Inc. (FENC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewsWire
- 3 months ago - Fennec Pharmaceuticals Inc. (FENC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025 - GlobeNewsWire
- 5 months ago - Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany - GlobeNewsWire
- 6 months ago - Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales - GlobeNewsWire